Company Search:
Advanced Search
Sponsored Links
Seres Therapeutics Inc Company Snapshot
Seres Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seres Therapeutics Inc with three other companies in this sector in UNITED STATES : Regenxbio Inc (2019 sales of $35.23 million of which 100% was Biotechnology), Principia Biopharma Inc ($35.16 million of which 100% was Biopharmaceutical), and Evolus Inc ($34.93 million of which 100% was PHARMACEUTICAL PREPARATIONS).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Seres Therapeutics Inc
  Stock Performance Chart for Seres Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 4.64
(Figures in U.S. Dollars)
1 Week 24.1%   13 Weeks 2.9%  
4 Weeks 0.9%   52 Weeks 72.5%  
Seres Therapeutics Inc Key Data:
  Ticker: MCRB Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 34,505,000
(Year Ending Jan 2020).
Employees: 108
  Currency: U.S. Dollars Market Cap: 348,611,710
  Fiscal Yr Ends: December Shares Outstanding: 75,131,834
  Share Type: Ordinary Closely Held Shares: 7,171,605
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.